Safeguarding COVID-19 Research, Other Intellectual Property
Russell Koste, CSO of Alexion Pharmaceuticals, Spotlights Challenges, Mitigation Steps
May 28, 2020
Audio is streamed directly from the publisher (ismg-cdn.nyc3.cdn.digitaloceanspaces.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
About this episode
As cyberthreats to medical research on COVID-19 - and other intellectual property - grow, organzations must take critical steps to prevent the theft of their "innovation capital," says Russell Koste, chief security officer of Alexion Pharmaceuticals.